Wordt geladen...
Current treatment algorithm for the management of lower-risk MDS
Lower risk myelodysplastic syndromes (MDS), defined as MDS with a Revised International Prognostic Scoring System score ≤3.5 points, will remain a challenging entity in 2018. Supportive care continues to be the linchpin of treatment, although the options to reduce transfusion needs are broadening. T...
Bewaard in:
| Gepubliceerd in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142548/ https://ncbi.nlm.nih.gov/pubmed/29222293 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|